1-3 of 3
Tetsuya Fukumoto
Close
Sort by
Journal Articles

Clinical Effects of Tacrolimus Blood Concentrations Early after Allogeneic Hematopoietic Stem Cell Transplantation

Hiroyuki Kubo, Osamu Imataki, Tetsuya Fukumoto, Tomoya Ishida, Yukiko Hamasaki Kubo, Shunsuke Yoshida, Shumpei Uchida, Makiko Uemura, Haruyuki Fujita, Norimitsu Kadowaki
Journal: Blood
Blood (2023) 142 (Supplement 1): 7026.
https://doi.org/10.1182/blood-2023-178583
Published: 2023
Journal Articles

Chemotherapy for Acute Myeloid Leukemia Can Compensate Other Adverse Prognostic Factors in Elderly: A Retrospective Longitudinal Cohort Study in a Local Community, Japan

Osamu Imataki, MD, Hiroaki Ohnishi, MD, Yasunori Kawachi, M.D., Makoto Ide, M.D., Ph.D., Makiko Uemura, M.D., Kimihiro Kawakami, M.D., Ph.D., Akihito Matsuoka, M.D., Ph.D., Masato Waki, M.D., Ph.D., Hidetaka Takimoto, MD, Yasuo Hoshijima, M.D., Ph.D., Tetsuya Fukumoto, M.D., Ph.D., Kensuke Matsumoto, M.D., Ph.D., Fusako Waki, MD, Teruhisa Taoka, M.D., Ph.D., Takuya Matsunaga, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 3582.
https://doi.org/10.1182/blood.V120.21.3582.3582
Published: 2012
Journal Articles

Gab1 Is Involved in Erythropoietin Receptor-Mediated Survival Signal through Activation of the Erk Pathway.

Tetsuya Fukumoto, MD, Yoshitsugu Kubota, MD, PhD, Akira Kitanaka, MD, PhD, Fusako Waki, MD, Osamu Imataki, MD, PhD, Hiroaki Ohnishi, MD, PhD, Toshihiko Ishida, MD, PhD, Terukazu Tanaka, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 2207.
https://doi.org/10.1182/blood.V110.11.2207.2207
Published: 2007